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Abstract—Nanostructured biosensors with the aim of 
electroactive cancer-drug detection were investigated. The aim of 
this work is improvement of the sensitivity and limit of detection 
of two differently nanostructured biosensors to find out the best 
choice for quantifying the concentration of etoposide, as a widely 
used electroactive cancer drug, in its therapeutic range. To this 
purpose etoposide concentrations, ranging from zero to 60 μM, 
were sensed at multi-walled carbon nanotube and gold 
nanoparticle functionalized bioelectrodes using cyclic 
voltammetry. The optimum scan? rate for voltammetric 
experiments was found out equal to 70 mV s-1 and 130 mV s-1 for 
multi-walled carbon nanotube and gold nanoparticle based 
electrodes, respectively. For nanostructuring the electrodes, the 
optimum nanomaterial mass were experimentally obtained for 
multi-walled carbon nanotube and gold nanoparticle based 
electrodes equal to 20 μg (4314 mm2 of additional electroactive 
surface area) and 104 μg (6471 mm2 of additional electroactive 
surface area), respectively. Bioelectrodes produced based on this 
optimized configurations showed sensitivity of 0.98 ± 0.41 μA μM-
1 cm-2 and 1.43 ± 0.26 μA μM-1 cm-2, and limit of detection of 1.52 
± 0.89 μM and 1.29 ± 0.48 μM for multi-walled carbon nanotube 
and gold nanoparticles based electrodes. Comparing the limit of 
detection achieved in this work with the therapeutic range of 
etoposide verifies the possibility of using both nanostructured 
bioelectrodes for etoposide detection. However, gold nanoparticle 
based electrodes exhibit better electrochemical improvements in 
terms of both sensitivity and limit of detection. 
Keywords—nanostructure properties, electrochemical detection, 
gold nanoparticle, carbon nanotube, cyclic voltammetry, 
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I.  INTRODUCTION 
Electrochemical metabolite detection using nanostructured 
bioelectrodes as sensing element are very attractive for point of 
care therapeutic drug monitoring (TDM), or in other words the 
individualization of the dosing regime to maintain the blood 
drug concentration within a beneficiary range that is called 
therapeutic range. This is more significant for cancer drugs, 
which are mainly toxics, and have normally very narrow 
therapeutic ranges; prescribing a dosing regime for them, as a 
result, for a wide range of patients with different genetic profile 
and cultural background is very difficult. Others have 
investigated the effectiveness of the TDM in terms of the 
additional costs (time and money) of the process in reducing 
the mortality and morbidity of the diseases [1]. This shows the 
need for a low cost and fast TDM process, which also ensures 
the good enough communication between the TDM team 
members for better interpretation of the results [2][3][4]. 
Electrochemical bioelectrodes have shown to be a promising 
system to replicate the time-consuming and costly laboratory 
experiments and analysis that are used for TDM, currently. 
Therefore, they can be the connection between TDM and site 
testing, emergency room screening, bedside monitoring and 
home self-testing [5][6]. Electrochemical bioelectrodes provide 
an interface between redox site of target metabolite and 
electronic part of the biosensors. Most bioelectrodes act as 
transducers to convert biological events to electric current by 
applying a fixed potential over the electrode and target 
(amperometry), or sweeping? the applied potential in a range 
(voltammetry) and measuring the current. Amperometry 
experiments are beneficial because of their high sensitivity and 
large linear range, whilst voltammetry experiments provide the 
option of multi-target detection [7]. Many different enzymatic 
[3][9][10] and non-enzymatic [10][11][12] bioelectrodes have 
been proposed in literature that can be useful to this purpose. 
The role of nanostructuring in enhancing the electrochemical 
performance of bioelectrodes is widely studied and reported 
[13][14][15], but at our best knowledge there are not enough 
work done on the impact of physical nature of the different 
nanomaterials on the performance. The different effect of 
multi-walled carbon nanotubes (MWCNTs) and gold 
nanoparticles (GNPs) on enhancing the sensitivity and limit of 
detection (LOD) of H2O2-bioelectrodes is investigated 
somewhere else [16]. Similarly, direct electron transfer by 
enzymes has been investigated on MWCNT [17] and GNPs 
[9]. Moreover, nanoparticles are well know to support quantum 
phenomena both in case of conductive [18] and 
semiconductives ones [19]. The aim of this work is to compare 
and investigate the natural properties of the MWCNTs and 
GNPs on improving the performance of bioelectrodes for 
electroactive-drug detection. The optimum performance by 
means of each nanomaterial is obtained by modifying the 
additional ElectroActive Surface Areas (EASA) and scan rate 
of voltammetry experiments. Then the sensitivity of produced 
bioelectrodes with these optimized configurations are 
compared to figure out which one can be the better choice for 
biosensing applications. 
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II. MATERIAL AND METHODS 
A. Nano materials 
Biosensors were fabricated based on commercial screen-
printed electrodes (SPEs) manufactured by Metrohm 
(DRP−110). They consist of graphite working electrode (area – 
0.12 cm2), graphite counter electrode and silver reference 
electrode. Powder of MWCNTs (diameter: 10 nm; length: 1 to 
2 μm; 90% purity), functionalized with COOH was purchased 
from DropSens (Spain), which was dispersed in chloroform to 
the concentration of 1 mg mL-1, and was sonicated for 1 hour to 
achieve a homogenous solution. Dispersion of hydrophilic 
Gold nanoparticles (GNPs; OD-1; 0.06 mg mL-1), 
functionalized with Tannic acid, with average diameter of 5.22 
± 0.01 nm (Fig. 2) was purchased from Sigma-Aldrich. 
Phosphate buffer saline (PBS-100mM; pH-7.4) was provided 
by Sigma-Aldrich, and solved in distilled water and stirred to 
obtain the homogenous solution. It was used as supporting 
electrolyte in experiments. Etoposide powder was purchased 
from Sigma-Aldrich and was dissolved in dimethyl sulfoxide 
(DMSO) to the concentration of 10 mM.  
B. Electrode preparation 
Functionalization of SPEs with nanostructures was carried 
out exploiting drop-casting technique for ease of action and 
minimizing the interferences. For instance, to prepare SPEs 
equipped with hydrophilic GNPs (GNP-SPEs), 290 μl of 0.06 
mg mL-1 stock dispersion was dropped over the working 
electrode (W.E.) in steps of 10 μl to obtain overall mass of 17.4 
μg of GNPs. Electrodes were stored at ambient temperature 
after each deposition for drying, and also for storage. 
Electroactive surface areas (EASA) have been calculated using 
specific surface area of each material and amount of deposited 
mass used for electrode preparation [20]. EASA has been used 
as the unit rather than mass to provide reasonable comparison 
between electrodes equipped with different types of 
nanomaterials, following the previous work of this group [16]. 
For scan rate optimization 3 electrodes were equipped with the 
optimized amount of MWCNTs (30 μg – 6471 mm2 of EASA) 
and GNPs (69.6 μg - 4314 mm2 of EASA). To optimize the 
amount of nanomaterial used for deposition (deposition mass 
optimization), 3 sets of electrodes were produced.  Each set 
contained 9 electrodes equipped with MWCNTs ranging from 
0 to 40 μg with step of 5 μg (bare SPE, MWCNT-SPE-1078, 
MWCNT-SPE-2157, …, MWCNT-SPE-8628).  Next, same 
process were done to prepare 3 sets of GNP-SPEs (bare SPE, 
GNP-SPE-1078, …, GNP-SPE-8628). For instance, 17.4 μg of 
GNPs were deposited over W.E. of an electrode to produce 
GNP-SPE-1078. TEM (Fig. 2) and SEM images (Fig. 1) have 
been taken using Tecnai Osiris device, and MERLIN device, 
respectively. All image analyses have been performed utilizing 
ImageJ software [21]. 
C. Electrochemical measurement apparatus and setup 
Autolab potentiostat/galvanostat (PGSTAT128N) was used 
for cyclic voltammetry (CV) under aerobic conditions. To 
obtain the Voltammograms, first 100 μl of etoposide solution 
(PBS; pH-7.4; as background electrolyte) covered the active 
part of the electrode. Device was configured to swap the 
voltage between -1 and +1 for 10 cycles to achieve a stable 
result. 
III. ELECTROCHEMICAL EXPERIMENTS AND RESULTS 
Electrochemical experiments started with two optimization 
steps: first, to figure out the best protocol for electrode 
preparation in terms of the amount of mass for deposition. 
Second, to find out the optimum scan rate used in voltammetry 
experiments in order to get highest peak amplitude.  
Figure 1,?SEM images of MWCNTs that were taken after deposition over the working electrode of a SPE. Left figure shows 
surface of working electrode, which is covered by MWCNTs.  Right figure, is the magnification of the specified area on the
left figure. MWCNTs have average diameter of 10 nm and length of 1 - 2 μm. 
2 μm 200 nm 
Figure 3, Averaged oxidation peak amplitude of etoposide. Electrodes were
equipped with 6471 mm2 of EASA using 30 μg of MWCNTs and examined
in a range of scan rate from 10 to 120 mVs-1?
?????????????? 
Figure 2, TEM image of hydrophilic sample of GNPs with average 
diameter of 5.22 ± 0.01 nm. One spherical GNP is pointed out on the
left figure. 
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A. MWCNT-SPEs optimization 
To find out the best scan rate for CV the deposition mass 
was fixed to 6471 mm2 (30 μg of MWCNTs). Concentration of 
etoposide in the target solution was set to 70 μM at this step 
(Etop-70). Three electrodes were prepared with this 
configuration and were tested using CV while varying the scan 
rate in a range of 10 mV s-1 to 120 mV s-1, with step of 10 mV 
s-1.  
 Acquired voltammograms (data not shown) have been 
analyzed by Nova software to obtain the measured peak 
amplitudes (Fig. 3). Based on these data, scan rate of 70 mV s-1
can provide highest peak amplitude for MWCNT-SPEs. This 
scan rate has been used for next optimization step and 
sensitivity experiments of MWCNT-SPEs. At second 
optimization step, MWCNT-SPEs were prepared with EASA 
ranging from zero (bare-SPE) to 8628 mm2 as explained 
earlier, and practiced by CV to detect Etop-70. Scan rate of CV 
experiment was fixed to the result of the last step (70 mV s-1). 
After analyzing the results the average of peak amplitudes are 
presented in Fig. 4. SPEs equipped with 4314 mm2 of 
additional EASA have exhibited highest peak amplitude. As a 
result, this deposition configuration and 70 mV s-1 as scan rate 
was used for MWCNTs-SPEs sensitivity experiments.  
B. GNP-SPEs optimization 
Scan rate and deposition mass optimization for GNP-SPEs 
were carried out with the same process as described for 
MWCNT-SPEs. The only differences were the deposited 
EASA (4314 mm2) and the maximum tested scan rate (150 mV 
s-1) for scan rate optimization of GNP-SPEs. Acquired 
averaged peak amplitudes for scan rate and EASA 
optimizations are presented in Fig. 5 and Fig. 6 respectively. 
The scan rate extension to 150 mV s-1 was due to the fact that 
the peak was growing until 130 mV s-1.  
According to the data presented by the graph, 130 mV s-1 
and 6471 mm2 were chosen for GNP-SPE as experiment and 
electrode preparation configurations.  
C. Sensitivity and limit of detection comparison 
To compare the MWCNT-SPEs and GNP-SPEs in terms of 
sensitivity and LOD, three electrodes were produced for each 
nanomaterial using optimum additional EASA and tested by 
CV using optimum scan rate configuration. Concentration of 
target solution, etoposide (PBS as background solution), was 
increased from 0 (blank measurement) to 60 μM in steps of 10 
μM, corresponding to? the therapeutic range of etoposide [22]. 
Acquired voltammograms related to the experiments performed 
on MWCNT-SPEs and hydrophilic GNP-SPEs are not shown 
here. Peak amplitudes were analyzed and measured for 
different concentrations of etoposide to obtain calibration 
curve. LODs were calculated using the standard deviation of 
three blank measurements related to each set of MWCNT-
SPEs and GNP-SPEs [23]. Calibration curves and measured 
data related to sensitivity and LODs are presented in Fig. 7 and 
Table 1 respectively. Presented data shows better performance 
for GNP-SPEs in terms of either sensitivity or LOD.   
Figure 4, Averaged oxidation peak amplitude related to etoposide detection 
using CV technique. Scan rate were fixed to 70 mV s-1 and SPEs were
nanostructured with different amount of EASA as shown on the horizontal 
axis of the graph. 4314 mm2 demonstrates highest peak amplitude. 
Figure 6, Averaged oxidation peak amplitude related to etoposide detection
using CV technique. Scan rate were fixed to 130 mV s-1 and SPEs were
nanostructured with different amount of EASA as shown on the horizontal
axis of the graph. 6471 mm2 demonstrates highest peak amplitude. 
Figure 5, Averaged oxidation peak amplitude of etoposide. Electrodes were
equipped with 4314 mm2 of EASA using 69.6 μg of GNPs and examined in
a range of scan rate from 10 to 150 mVs-1 
Figure 7, Calibration curves related to GNP-SPEs and MWCNT-SPEs are 
presented in this figure for comparison. These electrodes were prepared using 
6471 and 4314 mm2 of additional EASA respectively, and were experimented 
with CV to detect etoposide with concentration varying from 0 to 60 μM as is 
shown on the horizontal axis. Scan rates were set to 130 and 70 mVs-1, 
respectively. Data points are shifted, to provide more clarity of sensitivity 
differences, by 2.95 μA and 1.2 μA for MWCNT-SPEs and GNP-SPEs 
respectively. 
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 IV. CONCLUSION 
 
 
 
 
 
 
 
 
 
 
 
 
Better electrochemical properties of GNP-SPEs (5 nm in 
diameter) respect to MWCNT-SPEs (higher sensitivity and 
better LOD) on detection of etoposide are experimentally 
proven. This enhancement is partly owing to higher affinity of 
hydrophilic GNPs to electroactive xenobiotics as etoposide, 
and partly due to the small dimension of nanoparticles. Taking 
into account that both functionalized electrodes were tested at 
their optimum configurations, it can be inferred that the size of 
nanoparticles that is under the 10 nm have taken a significant 
role. This is already discussed that GNPs with decreasing 
diameter can provide electrochemical enhancements. For 
instance, in [24] it is presented that by decreasing the size of 
GNPs from 13 nm to 6 nm and then to 3.5 nm, maximum 
current is increased to 66.2 μA, 73.8 μA, and 76.2 μA, 
respectively. However, this phenomenon is not observed 
experimentally on electroactive drug detection. Low enough 
LOD, high sensitivity (even at very low concentrations) and 
simple functionalization make the proposed GNP-SPEs a 
suitable option for detection of electroactive drugs as 
etoposide. Nevertheless, there are some other factors to be 
addressed including the effect of nanoparticles dimension on 
the performance and the physics behind it, which is the target 
of this group future works. 
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 Sensitivity (μAμM-1cm-2) LOD (μM) 
MWCNT-SPEs 0.98 ± 0.41 1.52 ± 0.89 
GNP-SPEs 1.43 ± 0.26 1.29 ± 0.48 
TABLE I. ELECTROCHEMICAL RESULTS RELATED TO MWCNT-SPES 
AND HYDROPHILIC GNP-SPES ARE PRESENTED FOR COMPARISON 
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